Novel FGFR2::ZCCHC24 Fusion in Dysembryoplastic Neuroepithelial Tumor
Open Access
- 26 September 2022
- journal article
- letter
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 81 (12), 1029-1032
- https://doi.org/10.1093/jnen/nlac087
Abstract
No abstract availableFunding Information
- NIH
This publication has 15 references indexed in Scilit:
- The genetic landscape of gangliogliomaActa Neuropathologica Communications, 2018
- Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activationActa Neuropathologica, 2018
- Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathwayActa Neuropathologica, 2018
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyActa Neuropathologica, 2016
- The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation SequencingClinical Cancer Research, 2016
- BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomasJournal of Surgical Oncology, 2014
- One Hundred and One Dysembryoplastic Neuroepithelial Tumors: An Adult Epilepsy Series With Immunohistochemical, Molecular Genetic, and Clinical Correlations and a Review of the LiteratureJournal of Neuropathology and Experimental Neurology, 2011
- Towards a knowledge-based Human Protein AtlasNature Biotechnology, 2010
- Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants: clinical profile, MRI, and histopathologyNeuroradiology, 2009
- Dysembryoplastic Neuroepithelial Tumor: A Surgically Curable Tumor of Young Patients with Intractable Partial SeizuresNeurosurgery, 1988